Physician

Samir I. Sayegh, MD, PHD

According to 2025 Medicare claims, Samir Sayegh, MD, PHD (NPI: 1104918176) practices ophthalmology in the Champaign-Urbana, IL market, with the plurality of this provider's patient population coming from Champaign, IL. This provider's primary affiliated billing organization is EYE CENTER LLC (NPI: 1356663967; TIN: 27-1321246) and primary practice location at 61820-9998.

Sayegh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 359 traditional Medicare patients, billed 3,892 HCPCS/CPT codes, and received $400,254 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,204 prescription claims across 236 beneficiaries totaling $78,521 in drug costs, led by Combigan (Brimonidine Tartrate/Timolol). Open Payments data shows 2 records totaling $49. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $332,671 and ending at $400,254. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$826K$1.7M2015 Medicare payment: $332,671 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $372,155 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $417,449 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $450,329 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $471,189 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $268,325 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $310,591 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $396,027 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,651,073 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $400,254 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153506,821$332,671
20164017,557$372,155
20174089,140$417,449
20183897,873$450,329
20194247,546$471,189
20203084,212$268,325
20212494,951$310,591
20224364,902$396,027
202364011,344$1,651,073
20243593,892$400,254

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$71K$142K2015 Drug cost: $58,721 (USD; Tot_Drug_Cst)2016 Drug cost: $72,808 (USD; Tot_Drug_Cst)2017 Drug cost: $80,234 (USD; Tot_Drug_Cst)2018 Drug cost: $103,015 (USD; Tot_Drug_Cst)2019 Drug cost: $126,948 (USD; Tot_Drug_Cst)2020 Drug cost: $142,443 (USD; Tot_Drug_Cst)2021 Drug cost: $108,039 (USD; Tot_Drug_Cst)2022 Drug cost: $88,481 (USD; Tot_Drug_Cst)2023 Drug cost: $104,907 (USD; Tot_Drug_Cst)2024 Drug cost: $78,521 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015174720$58,721
2016233980$72,808
20172541,143$80,234
20182661,263$103,015
20193031,388$126,948
20202951,512$142,443
20212331,207$108,039
20222291,023$88,481
20232641,392$104,907
20242361,204$78,521

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system244578$76
67028Injection of drug into eye104261$61
92134Imaging of retina317641$26
92250Photography of the retina242512$25
92020Exam of the internal drainage system of eye6272$19

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CombiganBrimonidine Tartrate/Timolol822,792$20,497
LumiganBimatoprost602,275$19,181
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol571,910$6,421
Acetazolamide ErAcetazolamide614,148$4,394
LatanoprostLatanoprost41317,702$3,893

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$49Rayner Intraocular Lenses Limited
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Samir I. Sayegh, MD, PHD?

Tedicare shows public-source Medicare data for Samir I. Sayegh, MD, PHD (NPI 1104918176), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Samir I. Sayegh, MD, PHD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Samir I. Sayegh, MD, PHD?

Samir I. Sayegh, MD, PHD is linked to EYE CENTER LLC (billing NPI 1356663967) in the available physician profile data.

Does Samir I. Sayegh, MD, PHD have Open Payments data?

Samir I. Sayegh, MD, PHD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.